/Investor DB

Deerfield Management Company — 2026 Investments

4 investments dated 2026 · listed companies and verified rows first · show all

Alpfa Medicalalpfamed.comSep 2026

AlpfaMed develops a Pulsed Field Ablation (PFA) technology that uses targeted, heat-free electrical energy to remodel prostate tissue and treat Benign Prostatic Hyperplasia (BPH).

HealthtechMedical DevicesPalo Alto, US

Allan Zingeler(Executive Officer, Director)inMichael Wiley(Executive Officer, Director)inRupa Patel(Executive Officer)

BoardDavid Bonita(Director)Andrew ElBardissi(Director)Michael Hurley(Director)

Shineshinetext.comFeb 2026

Brooklyn, US

Marah Lidey(Executive Officer, Director)Naomi Hirabayashi(Executive Officer, Director)

BoardVictoria Song(Director)

Co-investorsComcast VenturesLaunchCapitalFidelity InvestmentsOaktreeSumitomo Corporation

Soonsoon.appin𝕏Feb 2026 · $240M

Soon is a portfolio management platform that automates buying and selling of assets across multiple exchanges using strategies like dollar-cost averaging and tax-loss harvesting.

Crypto & Web3FintechSalt Lake City, US

Michael Shattuck(Founder)inAaron BylundChris Lovato

Co-investorsIdeashipSoma CapitalY CombinatorDragon CapitalFalls FintechFidelity Investments+2 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Ray Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.